Tardive dyskinesia is a movement disorder characterised by irregular, stereotyped, and choreiform movements associated with the use of antipsychotic medication. We aim to provide recommendations on the treatment of tardive dyskinesia. We performed a , This guideline provides evidence-based recommendations for the treatment of tardive syndromes, focusing on effective management strategies and therapeutic interventions., TD, tardive dyskinesia; VMAT2, vesicular monoamine transporter 2. * Level A is the strongest recommendation, established as effective, based on at least 2 consistent class I studies. Level B refers to probably effective treatment, derived from at least 1 class I study or 2 consistent class II studies., , , .